These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 358470)

  • 21. [Clinical aspects of viral respiratory infections].
    Pescetti G; Gozzelino F
    Minerva Med; 1980 Dec; 71(49):3599-605. PubMed ID: 6256690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Could preventive intranasal interferon lower the morbidity in children prone to respiratory illness?
    Douglas RM; Moore B; Miles HB; Pinnock CB
    Med J Aust; 1990 May; 152(10):524, 527-8. PubMed ID: 1692602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon: mechanisms of action and clinical value.
    Houglum JE
    Clin Pharm; 1983; 2(1):20-8. PubMed ID: 6192965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of different mouse interferons in mice infected with encephalomyocarditis (EMC).
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):49-55. PubMed ID: 6184029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of human leukocytic interferon for the prevention and treatment of respiratory viral diseases in children under hospital conditions].
    Vorotyntseva NV; Baramykova GP; Kuznetsov VP; Lozovskaia LS; Nefedova LA
    Pediatriia; 1975 Jan; (1):37-42. PubMed ID: 1129007
    [No Abstract]   [Full Text] [Related]  

  • 26. The virus causes of coughs and colds.
    Tyrrell DA
    Helv Med Acta Suppl; 1967 May; 47():52-9. PubMed ID: 4329280
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies with low molecular weight inducers of interferon in man.
    Niblack JF
    Tex Rep Biol Med; 1977; 35():528-34. PubMed ID: 211671
    [No Abstract]   [Full Text] [Related]  

  • 28. Symposium: The upper airways under attack.
    Eur J Respir Dis Suppl; 1983; 126():113-48. PubMed ID: 6233168
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospects for the clinical use of exogenous interferon.
    Cantell K
    Med Biol; 1977 Apr; 55(2):69-73. PubMed ID: 194114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of interferon in the response to infection.
    Tyrrell DA
    Proc R Soc Med; 1969 Mar; 62(3):297-8. PubMed ID: 5768360
    [No Abstract]   [Full Text] [Related]  

  • 31. [Infections with respiratory viruses].
    Popow-Kraupp T
    Ther Umsch; 1994 Aug; 51(8):563-8. PubMed ID: 7940414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinico-epidemiological efficacy of thymogen in acute respiratory viral infections in a military collective].
    Furgal SM; Degtiarev AA; Seryĭ SV; Khavinson VKh
    Voen Med Zh; 1993 Feb; (2):31-2, 80. PubMed ID: 8498021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and prevention of acute respiratory virus infections in children with leukocytic interferon.
    Arnaoudova V
    Virologie; 1976; 27(2):83-8. PubMed ID: 973346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of interferon for prevention of hospital infection in departments for respiratory diseases].
    Ketiladze ES; Alekseeva AA; Ivanova LA; Poliakova TG; Cheshik SG; Gaĭlonskaia IN; Mikhailova IM; Danilova VI
    Vopr Okhr Materin Det; 1970 Jun; 15(6):3-9. PubMed ID: 4317131
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of the efficacy of intranasal zinc gluconate.
    Yiu SC
    Clin Infect Dis; 2002 Jun; 34(12):1657. PubMed ID: 12032907
    [No Abstract]   [Full Text] [Related]  

  • 36. Transmission of viral respiratory infections in the home.
    Goldmann DA
    Pediatr Infect Dis J; 2000 Oct; 19(10 Suppl):S97-102. PubMed ID: 11052396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiviral effects of interferons and their inducers in experimental animals (author's transl)].
    Suzuki F; Saito N; Ishida N
    Tanpakushitsu Kakusan Koso; 1976 Apr; 21(4):260-70. PubMed ID: 796876
    [No Abstract]   [Full Text] [Related]  

  • 38. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds.
    Farr BM; Gwaltney JM; Adams KF; Hayden FG
    Antimicrob Agents Chemother; 1984 Jul; 26(1):31-4. PubMed ID: 6089652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers.
    Tannock GA; Gillett SM; Gillett RS; Barry RD; Hensley MJ; Herd R; Reid AL; Saunders NA
    Epidemiol Infect; 1988 Dec; 101(3):611-21. PubMed ID: 3215290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection.
    Monto AS; Shope TC; Schwartz SA; Albrecht JK
    J Infect Dis; 1986 Jul; 154(1):128-33. PubMed ID: 3011917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.